A Phase 2 Study of HX301 in Patients with High-grade Giloma
Clinical trial NCT06703255 · RECRUITING
Trial details
- NCT number
- NCT06703255
- Sponsor
- Hangzhou Hanx Biopharmaceuticals, Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-08
- Primary completion
- 2026-12-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.